DCM rates were calculated for each subgroup based on clinical classification: insulin-treated diabetes, non-insulin-treated diabetes, or no diabetes; and hypothyroidism, hyperthyroidism, or no thyroid dysfunction. This evidence concerns the gene INS and hyperthyroidism.